SANUWAVE Q2 net loss turns to USD 682,000; revenue falls 3% to USD 9.74 million vs Q2 FY25

SNWV•2026-08-06

Management commentary

Management cited weaker capital sales, increased used-system availability, and higher operating costs, while consumables revenue rose to USD 13.96 million.

First-half performance

For the first half, GAAP net loss narrowed to USD 2.12 million, helped by no change in fair value of derivative liabilities.

Second-quarter results

SANUWAVE Health posted a GAAP net loss of USD 682,000, swinging from net income in the year-ago quarter.

Revenue fell 3% to USD 9.74 million, reflecting a drop in UltraMIST system revenue to USD 2.29 million.

Gross margin narrowed 2 percentage points to 76%, while operating results turned to a USD 280,000 loss.

Sources

SANUWAVE Q2 net loss turns to USD 682,000; revenue falls 3% to USD 9.74 million vs Q2 FY25

Sec

SANUWAVE Q2 net loss turns to USD 682,000; revenue falls 3% to USD 9.74 million vs Q2 FY25

Management commentary

First-half performance

Second-quarter results

Related News

Ready Capital posts Q2 FY26 GAAP loss per share of $(0.63); distributable loss per share widens to $(0.47)

Pulse Biosciences enters equity distribution agreement for up to $75 million at-the-market offering

Zurn Elkay CAO Mark W. Peterson sells 25,000 shares for $1.33 million

Sources

SANUWAVE Q2 net loss turns to USD 682,000; revenue falls 3% to USD 9.74 million vs Q2 FY25

iRhythm to issue USD 50 million in unregistered shares as deal consideration for VitalConnect acquisition

Columbus Acquisition extends WISeSat.Space merger deal deadline to Oct. 31, 2026